Nykode Therapeutics AS (OSL:NYKD)

Nykode Therapeutics AS Statistics

Total Valuation

OSL:NYKD has a market cap or net worth of NOK 718.40 million. The enterprise value is 108.82 million.

Market Cap	718.40M
Enterprise Value	108.82M

Important Dates

The last earnings date was Monday, November 24, 2025.

Earnings Date	Nov 24, 2025
Ex-Dividend Date	n/a

Share Statistics

OSL:NYKD has 326.55 million shares outstanding. The number of shares has decreased by -22.32% in one year.

Current Share Class	326.55M
Shares Outstanding	326.55M
Shares Change (YoY)	-22.32%
Shares Change (QoQ)	+12.08%
Owned by Insiders (%)	15.08%
Owned by Institutions (%)	33.62%
Float	159.52M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	9.79
PB Ratio	0.72
P/TBV Ratio	0.73
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-0.99
EV / Sales	1.48
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-0.30

Financial Position

The company has a current ratio of 17.14, with a Debt / Equity ratio of 0.03.

Current Ratio	17.14
Quick Ratio	17.14
Debt / Equity	0.03
Debt / EBITDA	n/a
Debt / FCF	-0.08
Interest Coverage	-191.94

Financial Efficiency

Return on equity (ROE) is -9.10% and return on invested capital (ROIC) is -13.28%.

Return on Equity (ROE)	-9.10%
Return on Assets (ROA)	-12.08%
Return on Invested Capital (ROIC)	-13.28%
Return on Capital Employed (ROCE)	-26.02%
Revenue Per Employee	1.18M
Profits Per Employee	-1.77M
Employee Count	136
Asset Turnover	0.05
Inventory Turnover	n/a

Taxes

Income Tax	-56.31M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -14.18% in the last 52 weeks. The beta is 1.16, so OSL:NYKD's price volatility has been higher than the market average.

Beta (5Y)	1.16
52-Week Price Change	-14.18%
50-Day Moving Average	2.16
200-Day Moving Average	2.06
Relative Strength Index (RSI)	53.28
Average Volume (20 Days)	680,004

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, OSL:NYKD had revenue of NOK 73.37 million and -109.89 million in losses. Loss per share was -0.38.

Revenue	73.37M
Gross Profit	73.37M
Operating Income	-264.56M
Pretax Income	-166.20M
Net Income	-109.89M
EBITDA	-257.19M
EBIT	-264.56M
Loss Per Share	-0.38

Balance Sheet

The company has 638.53 million in cash and 28.96 million in debt, giving a net cash position of 609.58 million or 1.87 per share.

Cash & Cash Equivalents	638.53M
Total Debt	28.96M
Net Cash	609.58M
Net Cash Per Share	1.87
Equity (Book Value)	991.34M
Book Value Per Share	3.04
Working Capital	629.50M

Cash Flow

In the last 12 months, operating cash flow was -356.44 million and capital expenditures -868,957, giving a free cash flow of -357.31 million.

Operating Cash Flow	-356.44M
Capital Expenditures	-868,957
Free Cash Flow	-357.31M
FCF Per Share	-1.09

Margins

Gross margin is 100.00%, with operating and profit margins of -360.58% and -149.77%.

Gross Margin	100.00%
Operating Margin	-360.58%
Pretax Margin	-226.52%
Profit Margin	-149.77%
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

This stock pays an annual dividend of 1.00, which amounts to a dividend yield of 45.45%.

Dividend Per Share	1.00
Dividend Yield	45.45%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	22.32%
Shareholder Yield	68.79%
Earnings Yield	-15.30%
FCF Yield	-49.74%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on July 7, 2020. It was a forward split with a ratio of 5.

Last Split Date	Jul 7, 2020
Split Type	Forward
Split Ratio	5

Scores

OSL:NYKD has an Altman Z-Score of 6.95 and a Piotroski F-Score of 2.

Altman Z-Score	6.95
Piotroski F-Score	2